Page last updated: 2024-10-17

lactic acid and Hodgkin Disease

lactic acid has been researched along with Hodgkin Disease in 3 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Locatelli, SL1
Careddu, G1
Serio, S1
Consonni, FM1
Maeda, A1
Viswanadha, S1
Vakkalanka, S1
Castagna, L1
Santoro, A1
Allavena, P1
Sica, A1
Carlo-Stella, C1
Laster, BH1
Isaacson, C1
Perets, E1
Msamra, M1
Priel, E1
Kalef-Ezra, J1
Kost, J1
Thakur, V1
Sander, G1
Rab, ST1

Reviews

1 review available for lactic acid and Hodgkin Disease

ArticleYear
Hodgkin's disease and lactic acidosis.
    Nephron, 2001, Volume: 88, Issue:3

    Topics: Acidosis, Lactic; Aged; Aged, 80 and over; Fatal Outcome; Hodgkin Disease; Humans; Lactic Acid; Live

2001

Other Studies

2 other studies available for lactic acid and Hodgkin Disease

ArticleYear
Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 02-01, Volume: 25, Issue:3

    Topics: Animals; Benzopyrans; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Glycolysis; Hodgkin Dis

2019
Keeping those telomeres short! an innovative intratumoral long-term drug delivery system.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; DNA, Neoplasm; Drug Delivery Systems; Female;

2015